Synthesis and biological evaluation of a novel anticancer agent CBISC that induces DNA damage response and diminishes levels of mutant-p53.
Biochem Biophys Res Commun
; 562: 127-132, 2021 07 12.
Article
in En
| MEDLINE
| ID: mdl-34051576
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
DNA Damage
/
Tumor Suppressor Protein p53
/
Mutant Proteins
/
Antineoplastic Agents
Limits:
Animals
Language:
En
Journal:
Biochem Biophys Res Commun
Year:
2021
Document type:
Article
Affiliation country:
United States